Arthur T. Sands
2011 - Lexicon Pharmaceuticals
In 2011, Arthur T. Sands earned a total compensation of $1.9M as President, Chief Executive Officer and Director at Lexicon Pharmaceuticals, which was about the same as previous year.
Compensation breakdown
| Bonus | $195,000 |
|---|---|
| Option Awards | $803,822 |
| Salary | $580,000 |
| Stock Awards | $332,450 |
| Other | $6,845 |
| Total | $1,918,117 |
Sands received $803.8K in option awards, accounting for 42% of the total pay in 2011.
Sands also received $195K in bonus, $580K in salary, $332.5K in stock awards and $6.8K in other compensation.
Rankings
In 2011, Arthur T. Sands' compensation ranked 3,431st out of 10,747 executives tracked by ExecPay. In other words, Sands earned more than 68.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,431 out of 10,747 | 68th |
Division Manufacturing | 1,193 out of 3,960 | 70th |
Major group Chemicals And Allied Products | 233 out of 1,033 | 77th |
Industry group Drugs | 130 out of 781 | 83rd |
Industry Pharmaceutical Preparations | 108 out of 571 | 81st |
Source: SEC filing on March 14, 2014.
Sands' colleagues
We found four more compensation records of executives who worked with Arthur T. Sands at Lexicon Pharmaceuticals in 2011.
2011
Brian Zambrowicz
Lexicon Pharmaceuticals
Chief Scientific Officer
2011
Jeffrey Wade
Lexicon Pharmaceuticals
Chief Financial Officer
2011
Alan Main
Lexicon Pharmaceuticals
Executive Vice President of Pharmaceutical Research
2011
Pablo Lapuerta
Lexicon Pharmaceuticals
Chief Medical Officer
News
Nurix Therapeutics CEO Arthur Sands' 2023 pay falls 54% to $4.4M
March 27, 2024
Nurix Therapeutics CEO Arthur Sands' 2022 pay jumps 97% to $9.4M
March 24, 2023
Nurix Therapeutics COO Stefani Wolff receives $7.1M in 2021
March 25, 2022
Nurix Therapeutics CEO Arthur Sands' 2020 pay jumps 1,041% to $17M
March 25, 2021